Welcome to the SWSLHD Libraries Research Repository, an institutional repository which showcases the research output of South Western Sydney Local Health District staff, both past and present. The repository supports the SWSLHD Strategic Plan in their vision for the SWSLHD to be a leader in research and innovation.
Please use this identifier to cite or link to this item:
https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12679Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Choi, P. | - |
| dc.contributor.author | Merriman, E. | - |
| dc.contributor.author | Bennett, A. | - |
| dc.contributor.author | Enjeti, A. | - |
| dc.contributor.author | Tan, C. W. | - |
| dc.contributor.author | Goncalves, I. | - |
| dc.contributor.author | Hsu, D. | - |
| dc.contributor.author | Bird, R. | - |
| dc.date.accessioned | 2024-03-11T01:57:54Z | - |
| dc.date.available | 2024-03-11T01:57:54Z | - |
| dc.date.issued | 2024 | - |
| dc.identifier.issn | 14440903 (ISSN) | - |
| dc.identifier.uri | https://swslhd.intersearch.com.au/swslhdjspui/handle/1/12679 | - |
| dc.publisher | John Wiley and Sons Inc | - |
| dc.subject | Humans Purpura, Thrombocytopenic, Idiopathic Thrombocytopenia APRIL protein inhibitor avatrombopag B cell activating factor inhibitor corticosteroid efgartigimod alfa eltrombopag fostamatinib mycophenolate mofetil protein inhibitor rilzabrutinib rituximab romiplostim unclassified drug autoimmune thrombocytopenia bleeding cataract cost effectiveness analysis disease severity doctor patient relationship dose response drug cost drug half life drug metabolism drug receptor binding drug targeting drug tolerability Editorial funding health care access human liver toxicity low drug dose medical decision making monotherapy myeloid leukemia off label drug use platelet count practice guideline prognosis quality of life reimbursement risk reduction splenectomy thrombosis treatment contraindication treatment duration treatment failure treatment response idiopathic thrombocytopenic purpura | - |
| dc.title | Updated treatment options for immune thrombocytopenia | - |
| dc.type | Journal Article | - |
| dc.contributor.swslhdauthor | Hsu, Danny | - |
| dc.description.affiliates | The Canberra Hospital, Canberra, ACT, Australia John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia North Shore Hospital, Auckland, New Zealand Monash Health, Melbourne, VIC, Australia Monash University, Melbourne, VIC, Australia Calvary Mater, Newcastle, NSW, Australia University of Newcastle, Newcastle, NSW, Australia NSW Health Pathology, Newcastle, NSW, Australia Royal Adelaide Hospital, Adelaide, SA, Australia Peter MacCallum Cancer Centre, Melbourne, VIC, Australia Royal Melbourne Hospital, Melbourne, VIC, Australia Liverpool Hospital, Sydney, NSW, Australia University of New South Wales, Kensington, NSW, Australia Princess Alexandria Hospital, Brisbane, QLD, Australia | - |
| dc.identifier.doi | 10.1111/imj.16246 | - |
| dc.identifier.department | Liverpool Hospital, Department of Haematology | - |
| dc.type.studyortrial | Editorial | - |
| dc.identifier.journaltitle | Internal Medicine Journal | - |
| Appears in Collections: | Liverpool Hospital | |
Files in This Item:
There are no files associated with this item.
Items in Prosentient are protected by copyright, with all rights reserved, unless otherwise indicated.
